Anikó M. Sólyom
University of Arizona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anikó M. Sólyom.
Journal of Food Engineering | 2003
Erika Pfeiffer; Simone Höhle; Anikó M. Sólyom; Manfred Metzler
In order to investigate the stability of curcuminoids in physiological media, two samples with different composition of curcumin (CUR I), mono-demethoxycurcumin (CUR II) and bis-demethoxycurcumin (CUR III) were incubated in phosphate buffer and cell culture medium without or with fetal calf serum. The curcuminoids decomposed very rapidly (more than 90% within 12 h) when serum was omitted, but were more stable in the presence of serum. The stability differed between the curcuminoids: CUR I was the least, and CUR III was the most stable curcuminoid. Several degradation products of CUR I were detected, most of which were not yet identified; ferulic acid and vanillin were disclosed as minor products.
Journal of Medicinal Chemistry | 1997
Bhashyam S. Iyengar; Robert T. Dorr; David S. Alberts; Anikó M. Sólyom; Mary Krutzsch; William A. Remers
Three different types of 1,4-disubstituted anthracenes were synthesized, and their cytotoxicity in a panel of tumor cells was compared with that of the corresponding 9,10-disubstituted anthracenes. The panel contained human myeloma, melanoma, colon, and lung cancer cells and sensitive and multidrug-resistant murine L1210 leukemia cells. These compounds had [[(dimethylamino)ethyl]amino]methyl, N-[(dimethylamino)ethyl]carbamoyl, and carboxaldehyde (4,5-dihydro-1H-imidazol-2-yl)hydrazone side chains. The 1,4-diamide was more potent across the tumor panel than the corresponding 9,10-isomer, but the 1,4-diamine and the 1,4-hydrazone were less potent than their 9,10-isomers. Although the 1,4-hydrazone was active against P388 leukemia in mice, it was inactive against L1210 leukemia. Within each pair of compounds, the one with greater average potency against tumor cells gave a greater increase in the transition melt temperature of DNA.
Journal of Chemical Ecology | 2007
Kathleen L. Prudic; Smriti Khera; Anikó M. Sólyom; Barbara N. Timmermann
The viceroy–monarch and viceroy–queen butterfly associations are classic examples of mimicry. These relationships were originally classified as Batesian, or parasitic, but were later reclassified as Müllerian, or mutalistic, based on predator bioassays. The Müllerian reclassification implies that viceroy is unpalatable because it too is chemically defended like the queen and the monarch. However, unlike the queen and the monarch, the viceroy defensive chemistry has remained uncharacterized. We demonstrate that the viceroy butterfly (Limenitis archippus, Nymphalidae) not only sequesters nonvolatile defensive compounds from its larval host–plant, the Carolina willow (Salix caroliniana, Salicaceae), but also secretes volatile defensive compounds when disturbed. We developed liquid chromatography–mass spectrometry–mass spectrometry methods to identify a set of phenolic glycosides shared between the adult viceroy butterfly and the Carolina willow, and solid phase microextraction and gas chromatography–mass spectrometry methods to identify volatile phenolic compounds released from stressed viceroy butterflies. In both approaches, all structures were characterized based on their mass spectral fragmentation patterns and confirmed with authentic standards. The phenolics we found are known to deter predator attack in other prey systems, including other willow-feeding insect species. Because these compounds have a generalized defensive function at the concentrations we described, our results are consistent with the Müllerian reclassification put forth by other researchers based on bioassay results. It seems that the viceroy butterfly possesses chemical defenses different from its monarch and queen butterfly counterparts (phenolic glycosides vs. cardiac glycosides, respectively), an unusual phenomenon in mimicry warranting future study.
Phytomedicine | 2007
R.C. Lantz; Guanjie Chen; M. Sarihan; Anikó M. Sólyom; Shivanand D. Jolad; Barbara N. Timmermann
Phytochemistry | 2004
Shivanand D. Jolad; R. Clark Lantz; Anikó M. Sólyom; Guan Jie Chen; Robert B. Bates; Barbara N. Timmermann
Journal of Natural Products | 2006
Janet L. Funk; Janice N. Oyarzo; Jennifer B. Frye; Guanjie Chen; R. Clark Lantz; Shivanand D. Jolad; Anikó M. Sólyom; Barbara N. Timmermann
Phytomedicine | 2005
R.C. Lantz; Guanjie Chen; Anikó M. Sólyom; Shivanand D. Jolad; Barbara N. Timmermann
Arthritis & Rheumatism | 2006
Janet L. Funk; Jennifer B. Frye; Janice N. Oyarzo; Nesrin Kuscuoglu; Jonathan Wilson; Gwen McCaffrey; Gregory Stafford; Guanjie Chen; R. Clark Lantz; Shivanand D. Jolad; Anikó M. Sólyom; Pawel R. Kiela; Barbara N. Timmermann
Rapid Communications in Mass Spectrometry | 2005
Hongliang Jiang; Anikó M. Sólyom; Barbara N. Timmermann; David R. Gang
American Journal of Physiology-gastrointestinal and Liver Physiology | 2005
Pawel R. Kiela; Anna J. Midura; Nesrin Kuscuoglu; Shivanand D. Jolad; Anikó M. Sólyom; David G. Besselsen; Barbara N. Timmermann; Fayez K. Ghishan